BI-RADS stands for Breast Imaging Reporting and Data System. It is an assessment tool used to rate the results of a mammogram test. It also assesses your overall breast tissue density. With more dense ...

Based on data from a multi-site imaging trial involving more than 2,600 women, researchers say breast lesions categorized as 'probably benign' on supplemental screening ultrasound could be ...

What is a BI-RADS score? While this test can’t medically diagnose breast cancer, it can help identify anything abnormal. Not all abnormal findings are considered cancerous. Doctors use the BI-RADS ...

From August 2013 to December 2016, Barr and colleagues' prospective study (NCT02650778) enrolled patients with BI-RADS 1 or 2 on screening mammography and breast density C or D to undergo supplemental ...

OAK BROOK, Ill. - Women with mammographically detected breast lesions that are probably benign should have follow-up surveillance imaging at six months due to the small but not insignificant risk that ...

Receiving your mammogram results can be an emotional experience. Whether the news is positive or requires further investigation, it’s important to understand what these results mean for your breast ...

Breast cancer diagnosis using magnetic resonance imaging remains limited by high false-positive rates and substantial inter-reader variability, especially for lesions classified as Breast Imaging ...

Real-world evaluation of the reduction in complexity of ordering DNA sequencing tests through the adoption of Fast Healthcare Interoperability Resources (FHIR) standards. Compliance category scores as ...

Due to insufficient sensitivity of mammography in dense breasts, ultrasonography and MRI have been incorporated into breast screening, despite increasing false positive risks. While optical imaging ...

Pennsylvania Act 1 of 2023's criteria for supplemental breast cancer screenings disproportionately exclude Black women, exacerbating existing disparities in breast cancer diagnosis. The study found ...

Leesburg, VA, July 15, 2021--According to ARRS' American Journal of Roentgenology (AJR), return to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast US (ABUS) ...